Stuelpnagel John R

10x Genomics, Inc. · Director

Stuelpnagel John R is listed in filings as Director at 10x Genomics, Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including 3 public disclosures. Recent filings connect the profile to 10x Genomics, Inc. (TXG). The current snapshot covers public activity from Jun 13, 2024 to Jun 8, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.